IDEC Pharmaceuticals Corp / Biogen Inc
OFT closed case: Anticipated acquisition by Idec Pharmaceuticals Corp of Biogen Inc.
Affected market: Pharmaceuticals
On the basis of the information available to it, the Office of Fair Trading has decided that the proposed acquisition of Biogen Inc by IDEC Pharmaceuticals Corp does not qualify for investigation under the mergers provisions of the Enterprise Act 2002, because neither the UK turnover test nor the share of supply test in section 23 of the Act is met. A relevant merger situation has, therefore, not been created.